Coliseum Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Technical Institute
UTI
|
+$125M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$60M |
| 3 |
Fortrea Holdings
FTRE
|
+$17.2M |
| 4 |
GORV
Lazydays
GORV
|
+$2.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gildan
GIL
|
+$50.6M |
| 2 |
GMS
GMS Inc
GMS
|
+$28M |
| 3 |
Sonos
SONO
|
+$8.93M |
| 4 |
US Foods
USFD
|
+$8.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 37.38% |
| 2 | Industrials | 24.32% |
| 3 | Healthcare | 16.82% |
| 4 | Consumer Staples | 13.34% |
| 5 | Technology | 8.14% |
Similar funds
Coliseum Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Coliseum Capital Management held 12 positions worth $1.25B, up 30% from $959M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Coliseum Capital Management deployed $109M of net new capital in Q4 2023, opening 1 new position and adding to 3 existing holdings. Its largest new stake was R1 RCM Inc. Common Stock: 5,293,998 shares worth $56M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 51% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Gildan, an estimated $50.6M trimmed.
- Coliseum Capital Management's largest Q4 2023 buy was R1 RCM Inc. Common Stock: 5,293,998 shares worth $56M.
- Coliseum Capital Management added most to Universal Technical Institute in Q4 2023, an estimated $125M increase.
- Coliseum Capital Management's biggest Q4 2023 reduction was Gildan, cutting an estimated $50.6M.
- Coliseum Capital Management fully exited US Foods in Q4 2023, selling an estimated $8.7M.
- Coliseum Capital Management's ten largest holdings make up 98% of its $1.25B portfolio in Q4 2023.
- Coliseum Capital Management opened 1 new position and closed 1 in Q4 2023.
- Coliseum Capital Management's portfolio value rose 30% quarter-over-quarter to $1.25B.
Based on Coliseum Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.